Trending Assets
Top investors this month
Trending Assets
Top investors this month
CellaVision (CEVI-ST) - Bringing blood testing into the Digital Age

My opinion is that CellaVision is particularly interesting to investors looking for high-quality small-cap companies. This has been the focus of this blog/newsletter and CellaVision has been on my radar for close to a year.
CellaVision operates in the very profitable Medtech/Diagnostics industry. Companies with durable competitive advantages in this industry have tended to be very profitable investments for shareholders over the years, deserving premium valuations and profit margins. CellaVision has been no exception with a 17,65% CAGR in share price over the past 5 years. Despite its dominant market position in a niche part of the Medtech/Diagnostics industry, there are reasons to believe CellaVision is not done growing and should be a larger company in a few years than it is today.
Today, you will find out why CellaVision is worth researching if you are looking for high-quality businesses.
partnershipinvesting.substack.com
CellaVision (CEVI-ST) - Bringing blood testing into the Digital Age
CellaVision has the marks of a high-quality business. It has demonstrated an ability to grow very profitably in an attractive niche. Find out what makes CellaVision so special in today's post!

Related
Already have an account?